ContributorsPublishersAdvertisers

Dr. Chauncey on Isatuximab Combinations in Multiple Myeloma

onclive.com
 2021-12-01

Thomas R. Chauncey, MD, PhD, discusses the phase 3 ICARIA-MM trial (NCT02990338) and IKEMA (NCT03275285) trials with isatuximab-irfc (Sarclisa) combinations in patients with relapsed or refractory multiple myeloma. Thomas R. Chauncey, MD, PhD, associate professor, Department of...

www.onclive.com

Comments / 0

Comments / 0